PRFX
PRFX
NASDAQ · Pharmaceuticals

Prf Technologies Ltd

$1.94
+0.04 (+2.11%)
As of May 10, 10:57 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +516.5% upside
Low Target $8.59
Average Target $11.96
High Target $16.97
Current Price $1.94
Current
$1.94
Target
$11.96
$8.59 $11.96 avg $16.97
Scenario Analysis
Bear Case
$8.59
342.8%
Low target
Base Case
$11.96
+516.5%
Avg target
Bull Case
$16.97
+774.7%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$17.95
-89.2% from high
52-Week Low
$1.80
+8.0% from low
Target vs 52W High
$11.96
-33.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%